$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-039/395
  • C07K-016/28
  • A61K-051/10
  • C02F-001/00
  • C07K-016/30
  • A61K-031/475
  • A61K-031/573
  • A61K-031/675
  • A61K-031/704
  • A61K-038/19
  • A61K-038/20
  • A61K-038/21
  • A61K-039/00
출원번호 US-0225594 (2016-08-01)
등록번호 US-10113000 (2018-10-30)
발명자 / 주소
  • Grillo-Lopez, Antonio J.
출원인 / 주소
  • Biogen Inc.
대리인 / 주소
    Dreger, Ginger R.
인용정보 피인용 횟수 : 0  인용 특허 : 57

초록

New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise, in particular, administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkin's lymphomas.

대표청구항

1. A method for treating low grade or follicular non-Hodgkin's lymphoma (NHL) comprising administering to a patient 375 mg/m2 of rituximab during a cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapeutic regimen, wherein the CHOP chemotherapy and rituximab are administered

이 특허에 인용된 특허 (57)

  1. von Borstel Reid W. (Potomac MD) Bamat Michael K. (Potomac MD) Hiltbrand Bradley M. (Columbia MD), Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis.
  2. Anderson,Darrell R.; Hanna,Nabil; Newman,Roland A.; Reff,Mitchell E.; Rastetter,William H., Anti-CD20 antibodies.
  3. Gansoh Otto A. (Washington DC) Brechbiel Martin W. (Annandale VA), Antibody DTPA-type ligand conjugates.
  4. Senter Peter D. (Seattle WA) Saulnier Mark G. (Middletown CT) Brown Joseph P. (Seattle WA) Kerr David E. (Seattle WA), Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells.
  5. Gansow Otto A. (3003 Van Ness ; NW #W524 Washington DC 20008) Brechbiel Martin W. (2824 Summerfield Rd. Falls Church VA 22042), Backbone polysubstituted chelates for forming a metal chelate-protein conjugate.
  6. Gansow Otto A. (Washington DC) Brechbiel Martin W. (Falls Church VA), Backbone polysubstituted chelates for forming a metal chelate-protein conjugate.
  7. Gansow Otto A. (Washington DC) Brechbiel Martin W. (Falls Church VA), Backbone polysubstituted chelates for forming a metal chelate-protein conjugate.
  8. Gansow Otto A. (Washington DC) Brechbiel Martin W. (Annandale VA), Bifunctional DTPA-type ligand.
  9. Darrell R. Anderson ; Nabil Hanna ; Roland A. Newman ; Mitchell E. Reff ; William H. Rastetter, Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphoma.
  10. Robinson Randy R. (Los Angeles CA) Liu Alvin Y. (Santa Monica CA) Ledbetter Jeffrey A. (Seattle WA), Chimeric antibody with specificity to human B cell surface antigen.
  11. Robinson Randy R. (Walnut Creek CA) Liu Alvin Y. (Seattle WA) Ledbetter Jeffrey A. (Seattle WA), Chimeric antibody with specificity to human B cell surface antigen.
  12. Robinson Randy R. ; Liu Alvin Y. ; Ledbetter Jeffrey A., Chimeric antibody with specificity to human B cell surface antigen.
  13. Robinson Randy R. ; Liu Alvin Y. ; Ledbetter Jeffrey A., Chimeric antibody with specificity to human B cell surface antigen.
  14. Robinson, Randy R.; Liu, Alvin Y.; Ledbetter, Jeffrey A., Chimeric antibody with specificity to human B cell surface antigen.
  15. Robinson, Randy R.; Liu, Alvin Y.; Ledbetter, Jeffrey A., Chimeric antibody with specificity to human B cell surface antigen.
  16. Grillo-López, Antonio J., Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibodies.
  17. Antonio J. Grillo-Lopez, Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody.
  18. Grillo-López, Antonio J., Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody.
  19. Adam Lerner, Compositions and methods for the treatment of chronic lymphocytic leukemia.
  20. Hansen Hans J. (Westfield NJ) Goldenberg Milton D. (Short Hills NJ), Detection and treatment of infectious and inflammatory lesions.
  21. Rhodes Buck A. (Albuquerque NM) Zamora Paul O. (Albuquerque NM), Direct labeling of antibodies and other protein with metal ions.
  22. Uhr Jonathan W. (Dallas TX) Vitetta Ellen S. (Dallas TX) Scheuermann Richard H. (Carrollton TX), Epitope-specific monoclonal antibodies and immunotoxins and uses thereof.
  23. Anderson, Darrell R.; Hanna, Nabil; Leonard, John E.; Newman, Roland A.; Reff, Mitchell E.; Rastetter, William H., Expression and use of anti-CD20 Antibodies.
  24. Anderson,Darrell R.; Hanna,Nabil; Newman,Roland A.; Reff,Mitchell E.; Rastetter,William H., Expression and use of anti-CD20 antibodies.
  25. Queen Cary L. (Los Altos CA) Selick Harold E. (Belmont CA), Humanized immunoglobulins.
  26. Cheever Martin A. ; Disis Mary L., Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is a.
  27. Larka, Christopher Vance; Yi, Ching Sui Arthur; Kozak, Kenneth James, Immunoassay for H. Pylori in fecal specimens.
  28. Braun Jonathan (Sherman Oaks CA) Goodglick Lee A. (Los Angeles CA), Immunoglobulin superantigen binding to gp 120 from HIV.
  29. Goldenberg David M., Immunotherapy of B-cell malignancies using anti-CD22 antibodies.
  30. Goldenberg David M., Immunotherapy of B-cell malignancies using anti-CD22 antibodies.
  31. Reff Mitchell E. (San Diego CA), Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene pro.
  32. Kogan Timothy P. (Half Moon Bay CA) Somers Todd C. (Montara CA), Ketamine analogues for treatment of thrombocytopenia.
  33. DeFreitas Elaine C. (Villanova PA) Abrams J. Todd (Narberth PA), Lymphokine SAF and method of making.
  34. Hudziak Robert M. (Corvallis OR) Shepard H. Michael (Rancho Santa Fe CA) Ullrich Axel (Portola Valley CA) Fendly Brian M. (Half Moon Bay CA), Monoclonal antibodies directed to the HER2 receptor.
  35. Boss Michael A. (Slough GBX) Kenten John H. (High Wycombe GBX) Emtage John S. (High Wycombe GBX) Wood Clive R. (Near Fordingbridge GBX), Multichain polypeptides or proteins and processes for their production.
  36. von Eichborn Johann-Friedrich (Huttisheim DEX) Obert Hans-Joachim (Laupheim DEX) Brzoska Josef (Laupheim DEX), Process for treatment of diseases.
  37. Kaminski Mark S. (Ann Arbor MI) Butchko Gregory M. (Miami Lakes FL) Glenn Stephan D. (Davie FL) Wahl Richard L. (Ann Arbor MI), Radioimmunotherapy of lymphoma using anti-CD20.
  38. Kaminski Mark S. ; Butchko Gregory M. ; Glenn Stephan D. ; Wahl Richard L., Radioimmunotherapy of lymphoma using anti-CD20 antibodies.
  39. Kaminski Mark S. ; Butchko Gregory M. ; Glenn Stephan D. ; Wahl Richard L., Radioimmunotherapy of lymphoma using anti-CD20 antibodies.
  40. Kaminski Mark S. ; Butchko Gregory M. ; Glenn Stephan D. ; Wahl Richard L., Radioimmunotherapy of lymphoma using anti-CD20 antibodies.
  41. Kaminski Mark S. ; Butchko Gregory M. ; Glenn Stephan D. ; Wahl Richard L., Radioimmunotherapy of lymphoma using anti-CD20 antibodies.
  42. Kaminski, Mark S.; Butchko, Gregory M.; Glenn, Stephan D.; Wahl, Richard L., Radioimmunotherapy of lymphoma using anti-CD20 antibodies.
  43. Winter Gregory P. (Cambridge GBX), Recombinant altered antibodies and methods of making altered antibodies.
  44. Newman Roland A. (San Diego CA) Hanna Nabil (Olivenhain CA) Raab Ronald W. (San Diego CA), Recombinant antibodies for human therapy.
  45. Cabilly Shmuel (Monrovia CA) Heyneker Herbert L. (Burlingame CA) Holmes William E. (Pacifica CA) Riggs Arthur D. (La Verne CA) Wetzel Ronald B. (San Francisco CA), Recombinant immunoglobin preparations.
  46. Hellstrom Karl E. (Seattle WA) Hellstrom Ingegerd (Seattle WA) Goodman Gary E. (Bellevue WA), Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy.
  47. Anderson Darrell R. ; Hanna Nabil ; Leonard John E. ; Newman Roland A. ; Reff Mitchell E. ; Rastetter William H., Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen.
  48. Anderson Darrell R. ; Hanna Nabil ; Leonard John E. ; Newman Roland A. ; Reff Mitchell E. ; Rastetter William H., Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen.
  49. Anderson Darrell R. ; Hanna Nabil ; Leonard John E. ; Newman Roland A. ; Reff Mitchell E. ; Rastetter William H., Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen.
  50. Anderson, Darrell R.; Hanna, Nabil; Leonard, John E.; Newman, Roland A.; Reff, Mitchell E.; Rastetter, William H., Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma.
  51. van de Winkel J. G. J.,NLX, Transgenic mice expressing human Fc.alpha. and .beta. receptors.
  52. Lonberg Nils (San Francisco CA) Kay Robert M. (San Francisco CA), Transgenic non-human animals capable of producing heterologous antibodies.
  53. White, Christine; Grillo-Lopez, Antonio, Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody.
  54. White, Christine A.; Grillo-Lopez, Antonio J.; Curd, John G.; Desmond-Hellmann, Susan, Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies.
  55. White, Christine A.; Grillo-Lopez, Antonio J., Treatment of diffuse large-cell lymphoma with anti-CD20 antibody.
  56. White, Christine A.; Grillo-Lopez, Antonio J., Treatment of diffuse large-cell lymphoma with anti-CD20 antibody.
  57. White, Christine A.; Grillo-López, Antonio J.; Curd, John G.; Desmond-Hellmann, Susan, Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로